Testing effectiveness (Phase 2)Study completedNCT00239174What this trial is testingStudy to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese PatientsWho this might be right forObesity Sanofi 394
Testing effectiveness (Phase 2)Looking for participantsNCT06906874What this trial is testingActivated Charcoal Use in Chronic Kidney Disease PatientsWho this might be right forEnd Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder Mansoura University 40
Post-approval studies (Phase 4)Study completedNCT02092597What this trial is testingSafety Evaluation of Adverse Reactions in DiabetesWho this might be right forType 2 Diabetes Mellitus Charles University, Czech Republic 42
Early research (Phase 1)Study completedNCT05925920What this trial is testingStudy of Subcutaneously Administered ENT-03 for the Treatment of Obesity and DiabetesWho this might be right forObesityDiabetes Mellitus, Type 2 Metabolics Pharma 49
Not applicableUnknownNCT00290862What this trial is testingA Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by OsteoporosisWho this might be right forSpinal Fractures Orthovita d/b/a Stryker 256
Testing effectiveness (Phase 2)WithdrawnNCT00735683What this trial is testingA Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and SafetyWho this might be right forObesity Healios K.K.
Large-scale testing (Phase 3)Study completedNCT00147758What this trial is testingWelChol® and Sulfonylurea in Treating Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Daiichi Sankyo 400
Not applicableStudy completedNCT03156985What this trial is testingMulti-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in ChinaWho this might be right forType 2 Diabetes Mellitus AstraZeneca 3,000
Early research (Phase 1)Study completedNCT03586843What this trial is testingJNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple DoseWho this might be right forObesity Janssen Research & Development, LLC 52
Large-scale testing (Phase 3)Study completedNCT02911948What this trial is testingA Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic DrugsWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 210
Testing effectiveness (Phase 2)Study completedNCT00237185What this trial is testingThe Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit GeneWho this might be right forUnresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST) Novartis Pharmaceuticals 148
Not applicableEnded earlyNCT01892917What this trial is testingBIOFLOW-III Hungary Satellite RegistryWho this might be right forCoronary Artery DiseaseMyocardial Ischemia Biotronik Hungária Kft. 2,000
Early research (Phase 1)Study completedNCT00963768What this trial is testingA Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes MellitusWho this might be right forDiabetes Mellitus, Type 2 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 116
Testing effectiveness (Phase 2)Study completedNCT00036413What this trial is testingA 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral SclerosisWho this might be right forAmyotrophic Lateral Sclerosis Novartis Pharmaceuticals 44
Testing effectiveness (Phase 2)Study completedNCT00749788What this trial is testingEfficacy and Safety Study of JTT-302 in Subjects With Low HDL-C LevelsWho this might be right forDyslipidemia Akros Pharma Inc. 150
Post-approval studies (Phase 4)Study completedNCT02582242What this trial is testingComparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinWho this might be right forDiabetesType 2 Diabetes Mellitus Novo Nordisk A/S 437
Large-scale testing (Phase 3)Study completedNCT03141073What this trial is testingLong-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM SubjectsWho this might be right forDiabetes Mellitus, Type 2 Hua Medicine Limited 767
Early research (Phase 1)Active Not RecruitingNCT03283917What this trial is testingDaratumumab, Ixazomib, and Dexamethasone in AL AmyloidosisWho this might be right forNewly Diagnosed Primary AmyloidosisRecurrent Primary AmyloidosisRefractory Primary Amyloidosis M.D. Anderson Cancer Center 21
Not applicableEnded earlyNCT04008849What this trial is testingA Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456Who this might be right forInherited Metabolic Disorders (IMD) Magenta Therapeutics, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT01129648What this trial is testingStudy to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/GoutWho this might be right forGout BioCryst Pharmaceuticals 87